Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.
Global airlines race to fix A320 jets after Airbus recall
Death toll in Sri Lanka rises to 153 after Cyclone Ditwah
Hong Kong mourns victims of blaze that killed 128 and counting
Vast Russian overnight attack on Ukraine kills two, wounds dozens
Indonesia flood death toll climbs to 303 amid cyclone devastation
